Startseite/News/Press Releases/TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders Press ReleasesNewsTIF News (DE) TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders Weniger als eine Minute 211020_ TIF Announcement_COVID-19 Vaccine Boosters SchlagwörterHealthcare Professionals AtRisk COVID-19 Vaccines Sickle cell Vulnerable #news TIF News COVID-19 Pandemic COVID-19 Vaccinations Haemoglobin Disorders Thalassaemia Patients Weniger als eine Minute Facebook X LinkedIn Teile per E-Mail Drucken
